Wesley Self

Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.

Grant boosts vaccine effectiveness research

VUMC, NIH launch clinical trial to test novel therapies to protect host tissue against COVID-19

Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

The study team includes (seated, from left) Adrienne Baughman, CCRP; Bob McClellan; Wesley Self, MD, MPH; Christina Kampe, CCRP; (standing, from left) Rendie McHenry; Bo Stubblefield, MD; Jon Casey, MD, MSCI; Todd Rice, MD, MSc; Natasha Halasa, MD, MPH; Jakea Johnson, MPH; Jim Chappell, MD, PhD; Carlos Grijalva, MD, MPH; and Kelsey Womack, PhD. Not pictured are Julia Rhoads, PhD; Chris Lindsell, PhD; Keipp Talbot; MD, MPH; and Kimberly Hart, MA. (photo by Donn Jones)

Study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization

As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19.

Convalescent plasma improved survival in COVID-19 patients with blood cancers

Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).

Hydroxychloroquine does not help patients hospitalized with COVID-19: Study

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.

Self named VP for Clinical Research Networks and Strategy

Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center.

1 2 3